Omega Alpha SPAC (OMEG) Prices Upsized $120M IPO
Omega Alpha SPAC announced the pricing of its upsized $120 million IPO this evening and its shares are expected to begin trading on the Nasdaq under the symbol “OMEG” Thursday, January 7.
...READ MORE
Social Capital Hedosophia III (IPOC) Shareholders Approve Clover Health Deal
Social Capital Hedosophia Holdings Corporation III (NYSE:IPOC) shareholders approved its business combination with Medicaid insurer Clover Health at a special meeting earlier today.
The company said in a press release that 65% of shares participated in the vote and about 99.5% voted in favor of the deal.
...READ MORE
Poema Global Holdings Corp. (PPGHU) Prices Upsized $300M IPO
Poema Global Holdings Corp. announced the pricing of its upsized $300 million IPO this morning and its units are expected to begin trading on the Nasdaq under the symbol “PPGHU” Wednesday, January 6.
...READ MORE
Star Peak Corp II (STPC.U) Prices $350M IPO
Star Peak Corp II announced the pricing of its $350 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “STPC.U” Wednesday, January 6.
...READ MORE
Kairos Acquisition Corp. (KAIRU) Prices Upsized $240M IPO
Kairos Acquisition Corp. announced the pricing of its upsized $240 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “KAIRU” Wednesday, January 6.
...READ MORE
Sports Ventures Acquisition Corporation (AKICU) Prices $200M IPO
Sports Ventures Acquisition Corporation announced the pricing of its $200 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “AKICU” Wednesday, January 6.
...READ MORE
SC Health Corporation (SCPE) Teases LOI with Healthcare Technology Target
SC Health Corporation (NYSE:SCPE) announced in a filing this evening that it has entered into a non-binding letter of intent (LOI) to combine with a “next generation technology developer” with consumer healthcare applications. The teaser comes a week ahead of SC Health’s January 12 vote to extend its transaction deadline from January 14 to AprilRead More
Crucible Acquisition Corporation (CRU.U) Prices Upsized $225M IPO
Crucible Acquisition Corporation announced the pricing of its upsized $225 million IPO this morning and its units are expected to begin trading on the NYSE under the symbol “CRU.U” Tuesday, January 5.
...READ MORE
Benessere Capital Acquisition Corp. (BENEU) Prices $100M IPO
Benessere Capital Acquisition Corp. announced the pricing of its $100 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “BENEU” Tuesday, January 5.
...READ MORE
Fortress Value Acquisition Corp. III (FVT.U) Prices $200M IPO
Fortress Value Acquisition Corp. III announced the pricing of its $200 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “FVT.U” Tuesday, January 5.
...READ MORE
InterPrivate Acquisition Corp. (IPV) Adds $200M PIPE to Aeva Deal
InterPrivate Acquisition Corp. (NYSE:IPV) announced that institutional investor Sylebra Capital had agreed to invest $200 million in the SPAC to further fund the merger with automotive lidar-maker Aeva. The parties now expect Aeva to receive over $560 million in total proceeds from the deal including the estimated $243 million in InterPrivate’s trust and the $120Read More
Tottenham Acquisition I Ltd. (TOTA) Shareholders Approve Clene Deal
Tottenham Acquisition I Ltd. (NASDAQ:TOTA) announced in an 8-K filing that its shareholders approved its combination with biopharmaceutical firm Clene Nanomedicine Inc. at a special meeting earlier today.
The transaction was approved unanimously with 92.3% of shares participating, however Tottenham did not divulge redemption figures in the filing.
...READ MORE
FinTech IV (FTIV) to Combine with Perella Weinberg Partners in $975M Deal
FinTech Acquisition Corp. IV (NASDAQ:FTIV) announced this morning that it has entered into a definitive combination agreement with Perella Weinberg Partners (PWP) that would give the combined entity an implied equity value of $975 million. The global advisory firm has long been rumored to be in talks for a SPAC merger, as FT reported inRead More
dMY Technology Group, Inc. (DMYT) Completes Rush Street Deal
dMY Technology Group, Inc. (NYSE:DMYT) announced that it has closed its business combination with online betting platform Rush Street Interactive (“RSI”) following a shareholder vote earlier today. RSI provides customers an array of offerings, including real-money online casino wagering, online and retail sports wagering, and social gaming.
...READ MORE
Landcadia Holdings II (LCA) Completes Golden Nugget Deal
Landcadia Holdings II (NASDAQ:LCA) announced that it has completed its combination with online casino Golden Nugget Online Gaming following a shareholder vote earlier today.
Shares of the combined entity will begin trading on the Nasdaq tomorrow under the symbol “GNOG.”
...READ MORE
Viveon Health Acquisition Corp. (VHAQ.U) Prices $175M IPO
Viveon Health Acquisition Corp. announced the pricing of its $175 million IPO this morning and its units are expected to begin trading on the NYSE under the symbol “VHAQ.U” Wednesday, December 23.
...READ MORE
Healthcare Services Acquisition Corp (HCARU) Prices Upsized $288M IPO
Healthcare Services Acquisition Corporation announced the pricing of its upsized $288 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol HCARU” Wednesday, December 23.
...READ MORE
CF Acquisition Corp. IV (CFIVU) Prices Upsized $450M IPO
CF Acquisition Corp. IV announced the pricing of its upsized $450 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “CFIVU” Wednesday, December 23.
...READ MORE
7GC & Co. Holdings Inc. (VIIU) Prices Upsized $200M IPO
7GC & Co. Holdings Inc. announced the pricing of its upsized $200 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “VIIAU” Wednesday, December 23.
...READ MORE
LifeSci Acquisition Corporation (LSAC) Shareholders Approve Vincera Deal
LifeSci Acquisition Corporation (NASDAQ:LSAC) announced in an 8-K that its shareholders approved its combination with cancer drug developer Vincera Pharma at a special meeting earlier today.
The parties expect the transaction to close tomorrow, December 23.
...READ MORE